Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
Moran, Bundy, D. J. Becker, DiMeglio, Gitelman, Goland, Greenbaum, Herold, Marks, Raskin, Sanda, Schatz, Wherrett, Wilson, Krischer, Skyler, Type 1 Diabetes TrialNet Canakinumab Study Group, Pickersgill, de Koning, A-G Ziegler, Böehm, Badenhoop, Schloot, Bak, Pozzilli, Mauricio, Donath, Castaño, Wägner, Lervang, Perrild, Mandrup-Poulsen, AIDA Study Group2013 Jun 1Tijdschriftartikel
